Expectant treatment with curative intent in the prostate-specific antigen era: Triggers for definitive therapy
- 28 February 2006
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 24 (1), 51-57
- https://doi.org/10.1016/j.urolonc.2005.07.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Natural History of Early, Localized Prostate CancerJAMA, 2004
- Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohortBJU International, 2004
- Predictors of Treatment After Initial Surveillance in Men With Prostate Cancer: Results From CaPSUREJournal of Urology, 2003
- Lead time associated with screening for prostate cancerInternational Journal of Cancer, 2003
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI Journal of the National Cancer Institute, 2003
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002
- Prostate cancer trends in the era of prostate-specific antigen: An update of incidence, mortality, and clinical factors from the SEER databaseUrologic Clinics of North America, 2002
- CONSERVATIVE MANAGEMENT OF PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN ERA: THE INCIDENCE AND TIME COURSE OF SUBSEQUENT THERAPYJournal of Urology, 2001
- Long-term survival among men with conservatively treated localized prostate cancerPublished by American Medical Association (AMA) ,1995
- Impotence Following Radical Prostatectomy: Insight Into Etiology and PreventionJournal of Urology, 1982